Helius Medical Technologies’ (NASDAQ:HSDT; TSX:HSM) portable neuromodulation stimulator (PoNS) received FDA breakthrough designation for the treatment of gait deficit due to symptoms of multiple sclerosis (MS). The non...
Helius Medical Technologies (NASDAQ:HSDT; TSX:HSM) is opening a new PoNS clinic in Quebec City, Canada to be operated by Clinique Cortex. The PoNS device is authorized in Canada for the acute treatment of chronic...
Helius Medical Technologies (NASDAQ:HSDT; TSX:HSM) is transitioning from a development- to commercial-stage company as it rolls out its Health Canada-cleared PoNS medical device for the treatment of chronic balance...